Concepedia

Liuzhong Yang

LY

Statistics

Publications

8

Citations

395

H-Index

8

Active since

2006

Affiliations

First Affiliated Hospital of Xinxiang Medical University(Current)

Tianjin Medical University Cancer Institute and Hospital

Henan Medical University

First Affiliated Hospital of Zhengzhou University

Peking University

Liuzhong Yang is an author at First Affiliated Hospital of Xinxiang Medical University specializing in molecular oncology, oncology, and medicine.

Publications per year

2006–2024

8

Publications

8

Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study

Zhi Peng, Tianshu Liu, Jia Wei et al. · Cancer Communications · 2021 · 202 citations · Full text

, , +16

Recommendation on Item Graphs

Fei Wang, Sheng Ma, Liuzhong Yang et al. · Proceedings · 2006 · 39 citations

, , +8

Secretion of intestinal goblet cells: A novel excretion pathway of nanoparticles

Baoquan Zhao, Lan Sun, Wuxu Zhang et al. · Nanomedicine Nanotechnology Biology and Medicine · 2013 · 32 citations

, , +14

miR-218 is downregulated and directly targets SH3GL1 in childhood medulloblastoma

Jipeng Shi, Liuzhong Yang, Tuanjie Wang et al. · Molecular Medicine Reports · 2013 · 28 citations · Full text

, , +17

A phase II study of efficacy and safety of RC48-ADC in patients with locally advanced or metastatic HER2-overexpressing gastric or gastroesophageal junction cancers.

Zhi Peng, Tianshu Liu, Jia Wei et al. · Journal of Clinical Oncology · 2020 · 28 citations

, , +17

1–5 of 8